Ikänik Farms' wholly-owned, Colombian subsidiary Pideka SAS has received its production quota from the Colombian government for the production of psychoactive cannabis for the fiscal year, 2021.
"We would like to thank the Colombian government for their partnership in completing this process. We are excited to begin our psychoactive production, which will be led by our award-winning California cultivation team, who brings over eight decades of combined experience, to provide California quality to the international markets," said Brian Baca, CEO of Ikänik Farms.
Ikänik Farms is multinational operator and authorized producer of pharmaceutical-grade, psychoactive cannabis and has been permitted to cultivate a total of 135,000 plants to support dried cannabis flower and derivatives for commercial sale. The quota includes an initial 100,000 plants, across five varieties to support flower production: Pina Nariño, La Magdalena, Arequipe Kush, Tolima Limon, and Bacata Extra CBD with an annual production capacity of 3,500 kilograms. The THC content exceeds 20% THC in some varieties and is eligible for use in formula magistral nationally and internationally amongst participating LATAM countries and is eligible for exportation to the European Union to support the medical cannabis demand.
The additional 35,000 plants of the same varieties are approved to support 1,195 kilograms of flower production for the manufacturing of derivatives. The derivatives will be available for national and international sales.
To date, the Company has exported THC from Colombia to Mexico for commercial sale.
"We're proud to announce quota granted by the Colombian government for the production of psychoactive flowers and derivatives, as a result of our quality control measures taken within our indoor seed to sale process," said Borja Sanz de Madrid, President of Ikänik Farms International, Inc.
For more information:
Ikänik Farms
ikanikfarms.com